The London Health Sciences Center and the Lawson Clinical Research Institute in London, Ontario, Canada, have reported the first use of MRI-guided ultrasound ablation for the treatment of low-risk, prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ExAblate, focused, MRi-guided, ultrasound | 1 Comment »
In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ExAblate, focal, low risk, MRi-guided, Treatment, ultrasound | 24 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 